FDA's E-Cigarette Authorization: Fruity Vapes Not Better Than Tobacco Ones

FDA Greenlights Generic Rifapentine for Tuberculosis

Generic approved as part of combination regimens for active and latent pulmonary TB

Fauci Subpoenaed; Army, Navy Reinstate Flu Shot Requirement; Milder Ebola Symptoms?

Health news and commentary gathered by MedPage Today staff

Did Pete Hegseth Single-Handedly Raise the R0 of Flu?

A summer influenza outbreak didn't break epidemiology, it affirmed everything we know

Hospital Worker Allegedly Ate Body Parts; Outbreak Virus Mystery; New N95 Mask Policy

Health news and commentary gathered by MedPage Today staff

Mandatory Flu Shots for Recruits Restored as Boot Camp Outbreak Sickens Hundreds

Defense Secretary Pete Hegseth made the shot optional for the military at the end of April

Diagnosing Obstructive Sleep Apnea: Do At-Home Testing Devices Measure Up?

Home test showed 52 apnea-hypopnea events per hour in woman with high blood pressure, weight gain

ATS: American Thoracic Society

A Flu Season Without ACIP: The Question for Fall

While vaccine access and coverage will mostly hold this year, that's not good enough

Mucus-Clearing Agents Show No Benefit in Respiratory Failure

In patients with acute respiratory failure, carbocisteine and hypertonic saline — commonly used mucoactive agents in ICUs — do not shorten the duration of mechanical ventilation and are tied to harm.

Generic Triple Therapy Shows Promise in Cystic Fibrosis

A generic formulation of elexacaftor-tezacaftor-ivacaftor shows real-world benefits and appears safe in children and adolescents with cystic fibrosis, a study finds.

Pembrolizumab Favored Over Chemo for Pulmonary AEs

Researchers look at adverse effects beyond interstitial pneumonitis when comparing antibody monotherapy to chemotherapy in people with non-small cell lung cancer.

Air Trapping Predicts Pneumothorax After BLVR

Noninvasive analysis can help patients avoid in-hospital post-procedure monitoring.

Sanofi Says Rare Lung Disease Drug Outperforms Standard Care in Trial

(Corrects executive's name from Alaa Ahmed to Alaa Hamed in paragraphs 7 and 8)

Integrating Multidisciplinary Insights Into Treatment Decisions in Resectable NSCLC

Integrating Multidisciplinary Insights Into Treatment Decisions in Resectable NSCLC

Managing Treatment-Related Adverse Events Associated With Novel Immunotherapy-Based Combination Approaches in Advanced NSCLC

Managing Treatment-Related Adverse Events Associated With Novel Immunotherapy-Based Combination Approaches in Advanced NSCLC

Optimizing HER2 Assessment and Treatment in Advanced NSCLC: From Guidelines to the Clinic

Optimizing HER2 Assessment and Treatment in Advanced NSCLC: From Guidelines to the Clinic